AtaCor Medical completes $25m Series B
/
DateApr 28 2020
AtaCor said in a news release that the investment is earmarked for efforts to garner U.S. and European regulatory clearances for its novel extracardiac temporary pacing system, while it may also be used to fund development efforts for additional extracardiac therapies.
Read More →